Loading provider…
Loading provider…
Neurology Physician in Philadelphia, PA
NPI: 1003074584Primary Practice Location
PENNSYLVANIA HOSPITAL
800 Spruce St, Philadelphia, PA
Primary Employer
Perelman Center for Advanced Medicine
pennmedicine.org
HQ Phone
Get MD Meredith's Phone NumberMobile
Get MD Meredith's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 287 | 380 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 139 | 152 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 82 | 91 |
| 4 | 95970Electronic analysis of implanted brain spinal cord or peripheral neurostimulator generator system | 60 | 77 |
| 5 | 95983Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | 58 | 155 |
Authors: Andrew Siderowf, David Irwin, Lauren Elman, David Wolk
Journal: Acta Neuropathol
Publication Date: 2020-08-17
Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias.
Authors: David Irwin, Daniel Weintraub, David Wolk
Journal: Parkinsonism Relat Disord
Publication Date: 2022-08-06
Global Perspective on Telemedicine for Parkinson's Disease.
Authors: Shalash, Ali, Spindler, Meredith, Cubo, Esther
Journal: J Parkinsons Dis
Lead Sponsor: University of Rochester
Collaborators: Biogen, Takeda
Lead Sponsor: Takeda
Collaborators: Michael J. Fox Foundation for Parkinson's Research
Intervention / Treatment: DRUG: Placebo, DRUG: TAK-071
Lead Sponsor: Northwestern University
Collaborators: Michael J. Fox Foundation for Parkinson's Research, University of Rochester, University of Iowa
Intervention / Treatment: DRUG: Placebo, DRUG: Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), DRUG: Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)